annual EBIT:
-$112.22M+$117.09M(+51.06%)Summary
- As of today (May 24, 2025), ARQT annual earnings before interest & taxes is -$112.22 million, with the most recent change of +$117.09 million (+51.06%) on December 31, 2024.
- During the last 3 years, ARQT annual EBIT has risen by +$94.13 million (+45.62%).
- ARQT annual EBIT is now -2633.17% below its all-time high of -$4.11 million, reached on December 31, 2017.
Performance
ARQT EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBIT:
-$21.80M-$16.89M(-343.61%)Summary
- As of today (May 24, 2025), ARQT quarterly earnings before interest & taxes is -$21.80 million, with the most recent change of -$16.89 million (-343.61%) on March 31, 2025.
- Over the past year, ARQT quarterly EBIT has increased by +$5.78 million (+20.96%).
- ARQT quarterly EBIT is now -343.61% below its all-time high of -$4.91 million, reached on December 31, 2024.
Performance
ARQT quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBIT:
-$106.44M+$5.78M(+5.15%)Summary
- As of today (May 24, 2025), ARQT TTM earnings before interest & taxes is -$106.44 million, with the most recent change of +$5.78 million (+5.15%) on March 31, 2025.
- Over the past year, ARQT TTM EBIT has increased by +$77.45 million (+42.12%).
- ARQT TTM EBIT is now -1688.09% below its all-time high of -$5.95 million, reached on December 31, 2018.
Performance
ARQT TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
ARQT EBIT Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +51.1% | +21.0% | +42.1% |
3 y3 years | +45.6% | +65.1% | +54.3% |
5 y5 years | -160.2% | +23.9% | -64.2% |
ARQT EBIT Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | at high | +62.1% | -343.6% | +78.8% | at high | +65.3% |
5 y | 5-year | -160.2% | +62.1% | -343.6% | +78.8% | -64.2% | +65.3% |
alltime | all time | -2633.2% | +62.1% | -343.6% | +78.8% | -1688.1% | +65.3% |
ARQT EBIT History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2025 | - | -$21.80M(+343.6%) | -$106.44M(-5.1%) |
Dec 2024 | -$112.22M(-51.1%) | -$4.91M(-85.9%) | -$112.22M(-32.3%) |
Sep 2024 | - | -$34.88M(-22.2%) | -$165.81M(+0.4%) |
Jun 2024 | - | -$44.85M(+62.6%) | -$165.11M(-10.2%) |
Mar 2024 | - | -$27.58M(-52.9%) | -$183.90M(-19.8%) |
Dec 2023 | -$229.31M(-22.5%) | -$58.50M(+71.1%) | -$229.38M(-2.8%) |
Sep 2023 | - | -$34.18M(-46.3%) | -$235.99M(-22.5%) |
Jun 2023 | - | -$63.64M(-12.9%) | -$304.61M(-0.6%) |
Mar 2023 | - | -$73.06M(+12.2%) | -$306.38M(+3.6%) |
Dec 2022 | -$295.81M(+43.3%) | -$65.10M(-36.7%) | -$295.81M(-2.1%) |
Sep 2022 | - | -$102.81M(+57.2%) | -$302.03M(+17.9%) |
Jun 2022 | - | -$65.41M(+4.7%) | -$256.20M(+10.1%) |
Mar 2022 | - | -$62.49M(-12.4%) | -$232.80M(+12.8%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2021 | -$206.36M(+52.1%) | -$71.33M(+25.2%) | -$206.36M(+22.7%) |
Sep 2021 | - | -$56.98M(+35.6%) | -$168.13M(+12.5%) |
Jun 2021 | - | -$42.01M(+16.6%) | -$149.45M(+4.5%) |
Mar 2021 | - | -$36.04M(+8.9%) | -$143.07M(+5.4%) |
Dec 2020 | -$135.68M(+214.6%) | -$33.10M(-13.6%) | -$135.68M(+17.4%) |
Sep 2020 | - | -$38.30M(+7.5%) | -$115.58M(+25.7%) |
Jun 2020 | - | -$35.63M(+24.3%) | -$91.92M(+41.8%) |
Mar 2020 | - | -$28.65M(+120.5%) | -$64.83M(+50.3%) |
Dec 2019 | -$43.13M(+118.6%) | -$12.99M(-11.3%) | -$43.13M(+19.5%) |
Sep 2019 | - | -$14.65M(+71.6%) | -$36.09M(+68.3%) |
Jun 2019 | - | -$8.54M(+22.8%) | -$21.44M(+66.2%) |
Mar 2019 | - | -$6.95M(+16.8%) | -$12.90M(+116.8%) |
Dec 2018 | -$19.73M(+380.6%) | -$5.95M | -$5.95M |
Dec 2017 | -$4.11M | - | - |
FAQ
- What is Arcutis Biotherapeutics annual earnings before interest & taxes?
- What is the all time high annual EBIT for Arcutis Biotherapeutics?
- What is Arcutis Biotherapeutics annual EBIT year-on-year change?
- What is Arcutis Biotherapeutics quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Arcutis Biotherapeutics?
- What is Arcutis Biotherapeutics quarterly EBIT year-on-year change?
- What is Arcutis Biotherapeutics TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Arcutis Biotherapeutics?
- What is Arcutis Biotherapeutics TTM EBIT year-on-year change?
What is Arcutis Biotherapeutics annual earnings before interest & taxes?
The current annual EBIT of ARQT is -$112.22M
What is the all time high annual EBIT for Arcutis Biotherapeutics?
Arcutis Biotherapeutics all-time high annual earnings before interest & taxes is -$4.11M
What is Arcutis Biotherapeutics annual EBIT year-on-year change?
Over the past year, ARQT annual earnings before interest & taxes has changed by +$117.09M (+51.06%)
What is Arcutis Biotherapeutics quarterly earnings before interest & taxes?
The current quarterly EBIT of ARQT is -$21.80M
What is the all time high quarterly EBIT for Arcutis Biotherapeutics?
Arcutis Biotherapeutics all-time high quarterly earnings before interest & taxes is -$4.91M
What is Arcutis Biotherapeutics quarterly EBIT year-on-year change?
Over the past year, ARQT quarterly earnings before interest & taxes has changed by +$5.78M (+20.96%)
What is Arcutis Biotherapeutics TTM earnings before interest & taxes?
The current TTM EBIT of ARQT is -$106.44M
What is the all time high TTM EBIT for Arcutis Biotherapeutics?
Arcutis Biotherapeutics all-time high TTM earnings before interest & taxes is -$5.95M
What is Arcutis Biotherapeutics TTM EBIT year-on-year change?
Over the past year, ARQT TTM earnings before interest & taxes has changed by +$77.45M (+42.12%)